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diagnostic challenges that are associated with low sputum volume and smear-negative TB.
In healthcare facilities situated in low income countries that have a high burden of TB, ade-
quate decontamination of bronchoscopes is a challenge and often overlooked to save on
time and costs. This amplifies the risk of outbreaks and pseudo-outbreaks due to
Mycobacterium tuberculosis and nontuberculosis mycobacteria. In this minireview, we review
published literature of contaminated bronchoscopes causing pseudo-outbreaks of
M. tuberculosis and nontuberculosis mycobacteria in an effort to determine common
sources, and possible mitigation strategies in low-resource settings.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Bronchoscopy is an important diagnostic and therapeutic Vazque et al. [6], the highest number of contaminating inci-tool [1,2] in both ambulatory and inpatient healthcare settings
[1]. In the context of pulmonary tuberculosis, bronchoalveolar
lavage or bronchial biopsy have been proven to be essential
diagnostic tools, especially for patients who are unable to
expectorate sufficient sputum samples [3]. However, this
semicritical medical device [4] has also been reported to be
a source of both pseudo-infections and infectious outbreaks
[5]. An indication of an improperly disinfected bronchoscope
acting as a potential reservoir for contamination of both cul-
tures and patients can be gauged by the fact that the biobur-
den on bronchoscopes postwashing has been estimated to be
around 6.4  104 colony forming units/mL [4]. According to a
metadata analysis conducted from 1974 to 2004 by Seoane-dents was attributed to bronchoscopy and gastrointestinal
endoscopy. In the United States, contaminated fiberoptic
bronchoscopes are estimated to contribute to Mycobacterium
tuberculosis (MTB) nosocomial infections in 460–2300 human
immunodeficiency virus infected patients annually [7].
Additionally, pseudo-outbreaks due to environmental
microorganisms contaminating bronchoscopes have also
been reported [8]. However, data related to bronchoscope-
associated infections and pseudo-outbreaks is underreported
[5], with a dearth of data from low-income and developing
countries.
MTB, nontuberculous mycobacteria (NTM), and Pseu-
domonas aeruginosa are the most common pathogensost Office
Table 1 – Reported pseudo-outbreaks of nontuberculous mycobacteria and M. tuberculosis associated with bronchoscopy.
Study design Sample size (No. cases/No. of
bronchoscopies performed)
Reason for suspecting
outbreak
Organism Identified source of
contamination
Strain similarity Refs.
Retrospective study 14/1270 Unique strain of M.
cholnea isolated
+ inconsistent culture
findings with clinical
features of patients
M. cholonae subsp. abscessus Rinse water Not performed [10]
Retrospective study 7/16
1/16
3/16
Inconsistent culture
findings with clinical
features of patients
M. cholonae,
M. avium
M. gordonae
Rinse water
Water tank
Contaminated
glutaraldehyde
disinfectant
Not performed [11]
Retrospective study 17/21 Unusual No. of rapidly
growing AFB
M. xenopi Water RFLP [12]
Retrospective study 15/76 Not stated M. cholonae & M. fortuitum Mains water supply
Disinfectant tank
Not performed [13]
Retrospective case-
controlled study
18/21 Unusual increase in
isolation
M. cholonae Suction channel — [14]
Surveillance of
bronchoscopes
15/19
3/19
In response to previous
pseudoinfection
M. cholonae
M. avium intercellularae
Failure of AER
disinfection procedure
— [15]
Prospective-induced
study
— Efficacy of different
disinfectants: iodophore,
glutaraldehyde,
peraceticacid
M. gordonae Normal conditions for
disinfection inadequate
— [16]
Retrospective
+ prospective study
20 Unusual number of
rapidly growing AFB
M. cholonae Automated washer &
glutaraldehyde
disinfectant
DNA
fingerprinting
[17]
Retrospective study 9/57 Isolation at increased
frequency
M. cholonae Incoming water, water
filters, automated
bronchoscope washing
machine
REP-PCR [18]
Retrospective 22/75 Culture isolates were
inconsistent with clinical
features of patients
M. avium, M. intercellulare Water filter, hot & cold
water lines
Nested PCR
+ RFLP
[19]
Prospective study 5/7 Isolation ofM. gordonae in
BAL
M. gordonae Tap water, water supply
channels
PFGE [20]
Prospective study 4/5 Recurrent cases of
mycobacterial cross-
contamination
M. tuberculosis Contaminated suction
valve
Not performed [21]
Retrospective cohort
study
6/10 High incidence of M.
tuberculosis
M. tuberculosis Hole in bronchoscope
sheath
RFLP [22]
Retrospective cohort
study
2/3 No cases reported in
hospital the previous
year, suspected
nosocomial outbreak
M. tuberculosis Inadequate cleaning &
disinfection between
patients use. AER was not
approved
Spoligotyping
+ IS6110-based
RFLP
[23]
Note. AFB = acid-fast bacilli; BAL = bronchoalveolar lavage; M. =Mycobacterium; PCR = polymerase chain reaction; RFLP = restriction fragment length polymorphism.
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pseudo-outbreaks [5]. Bronchoscope contamination with
MTB is associated with extensive healthcare costs on the sys-
tem or on patients (where out-of-pocket expenses are
involved); false-positive cases are often investigated with
repeat cultures and advanced radiological investigations,
receive unnecessary antimycobacterial treatment, and risk
adverse effects of medication. An interesting study by Shim
et al. [9] highlights the limitations of direct amplification tests
created by the presence of false-positive results even by the
presence of a few dead MTB contaminating the broncho-
scopes. It is therefore imperative that special attention be
placed on addressing and circumventing not only false-
positive cultures but also false-positive molecular detection
tests such as Xpert MTB/RIF (Cepheid), and molecular probe
assays, due to bronchoscope contamination with
mycobacteria.
Reports of bronchoscope contamination with NTM and
MTB in literature from 1990 to 2016 are briefly outlined in
Table 1. While many NTM-associated outbreaks have been
reported, MTB-associated pseudo-outbreaks have not been
reported with equal frequency.
Possible factors indicated in the failure of the broncho-
scope decontamination process and leading to NTM infec-
tions include the design of bronchoscopes/endoscopes, an
over-reliance on automated endoscope reprocessors, mal-
functioning parts and damage during use, noncompliance of
decontaminating and handling guidelines, and use of con-
taminated/nonsterile water during washing [24–26]. Reported
causes of bronchoscopy-associated pseudo-outbreaks further
include damage to the internal channel of the bronchoscope,
the ability of bacteria to form biofilms that are difficult to
remove, along with inadequate cleaning with low- or
intermediate-level disinfectants. To prevent bronchoscope-
associated pseudo-outbreaks it is thus imperative to imple-
ment standardized decontamination guidelines, such as
those issued by the Centers for Disease Control and Preven-
tion [4], Association for Professionals in Infection Control
and Epidemiology [27], Food and Drug Administration [28],
and European Society of Gastrointestinal Endoscopy-
European Society of Gastroenterology and Endoscopy Nurses
and Associates [29]. There are, however, differences amongst
these guidelines; for example, for recommendations on
microbiological culture surveillance of bronchoscopes and
on the frequency of culture as well as on interpretation of
data. In light of such differences, a recommendation for an
initial validation study of the protocol to be used demonstrat-
ing its effectiveness in particular healthcare settings would be
useful [24]. While automated endoscope reprocessors are rec-
ommended by British Society of Gastroenterology and World
Gastroenterology Organisation in advanced settings, manual
cleaning, and disinfection are widely carried out in
resource-limited settings [30]. Ensuring quality control partic-
ularly in resource-limited healthcare settings using manual
cleaning and disinfection in particular, is a considerable chal-
lenge. Since water is identified as a major environmental
source of bronchoscope contamination, this challenge is
made all the more difficult by limited access to clean water
in many resource-limited settings. The Health Protection
Surveillance Center-Ireland recommends that there shouldbe no viable environmental mycobacteria/100 mL of postflush
water from bronchoscopes [31].
False-positive results of MTB smears, cultures, or molecu-
lar tests in bronchoscopically obtained samples are mainly
due to cross-contamination owing to insufficient decontami-
nation of bronchoscopes between use [5,32] or cross-
contamination in the laboratory [33,34]. Given that Xpert
MTB/RIF (Cepheid) is a closed system, and risk of cross-
contamination in the laboratory is lower, false-positive or
unexpected positive Xpert results on bronchoscope samples
are likely to be a consequence of inadequate decontamination
of the bronchoscope itself. Guidelines, however, do not focus
on decontamination to ensure complete removal of DNA or
antibiotic resistance genes from bronchoscopes.
Awareness and advocacy for stringent monitoring and
surveillance within the bronchoscope suite and disinfection
unit including monitoring of disinfectants used [31] thus
becomes essential. Implementing regular training and com-
petency assessment of personnel concerned with broncho-
scope disinfection would ensure compliance with
recommended guidelines.
While implementation and compliance of decontamina-
tion guidelines cannot be stressed enough, it is also necessary
that proper communication be established between the clini-
cians, bronchoscopists, and laboratories so that not only are
pseudo-outbreaks promptly detected but a coordinated
approach is implemented to handle postcontamination
responses.
As access to bronchoscopy, as well as its use in the diagno-
sis of TB and in particular smear-negative TB increases
[35–37], implementation of policies ensuring proper decon-
tamination of instruments being used as well as safety during
the procedure achieve paramount importance. We therefore
recommend that in addition to development of regional
and/or national guidelines for manual bronchoscope decon-
tamination to remove mycobacteria, innovative and low-
cost regional quality assurance programs be introduced to
ensure that specimens obtained through bronchoscopic tech-
niques are free of cross-contaminating mycobacterial DNA.Conflicts of interest
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